NIH state-of-the-science conference statement: Enhancing use and quality of colorectal cancer screening.

PubWeight™: 1.30‹?› | Rank: Top 10%

🔗 View Article (PMID 20140035)

Published in NIH Consens State Sci Statements on February 04, 2010

Authors

Donald Steinwachs1, Jennifer Dacey Allen, William Eric Barlow, R Paul Duncan, Leonard E Egede, Lawrence S Friedman, Nancy L Keating, Paula Kim, Judith R Lave, Thomas A LaVeist, Roberta B Ness, Robert J Optican, Beth A Virnig

Author Affiliations

1: Johns Hopkins Institute for Policy Studies, Baltimore, Maryland, USA.

Articles citing this

Comparative effectiveness of fecal immunochemical test outreach, colonoscopy outreach, and usual care for boosting colorectal cancer screening among the underserved: a randomized clinical trial. JAMA Intern Med (2013) 2.96

Levels and variation in overuse of fecal occult blood testing in the Veterans Health Administration. J Gen Intern Med (2012) 2.06

Interventions to improve care related to colorectal cancer among racial and ethnic minorities: a systematic review. J Gen Intern Med (2012) 1.49

Early detection of colon cancer-the kaiser permanente northwest 30-year history: how do we measure success? Is it the test, the number of tests, the stage, or the percentage of screen-detected patients? Perm J (2011) 1.16

Preferences for colorectal cancer screening tests and screening test use in a large multispecialty primary care practice. Cancer (2011) 1.13

Diagnostic value of CT-colonography as compared to colonoscopy in an asymptomatic screening population: a meta-analysis. Eur Radiol (2011) 1.07

Computer-delivered tailored intervention improves colon cancer screening knowledge and health beliefs of African-Americans. Health Educ Res (2012) 1.06

Colorectal cancer screening in primary care: translating research into practice. Med Care (2010) 0.92

The association between state mandates of colorectal cancer screening coverage and colorectal cancer screening utilization among US adults aged 50 to 64 years with health insurance. BMC Health Serv Res (2011) 0.91

Correlates of colorectal cancer screening among residents of Ohio Appalachia. J Community Health (2013) 0.90

Measurement of colorectal cancer test use with medical claims data in a safety-net health system. Am J Med Sci (2013) 0.83

The effects of test preference, test access, and navigation on colorectal cancer screening. Cancer Epidemiol Biomarkers Prev (2014) 0.83

Perceived barriers and facilitators of using a Web-based interactive decision aid for colorectal cancer screening in community practice settings: findings from focus groups with primary care clinicians and medical office staff. J Med Internet Res (2013) 0.80

Relationship of colorectal cancer awareness and knowledge with colorectal cancer screening. Colorectal Cancer (2015) 0.78

Universal Screening of Colorectal Cancers for Lynch Syndrome: Challenges and Opportunities. Dig Dis Sci (2015) 0.77

Adenoma detection at colonoscopy by polypectomy in withdrawal only versus both insertion and withdrawal: a randomized controlled trial. Surg Endosc (2014) 0.77

Assessing family history of chronic disease in primary care: Prevalence, documentation, and appropriate screening. Can Fam Physician (2017) 0.75

Effectively Communicating Colorectal Cancer Screening Information to Primary Care Providers: Application for State, Tribe or Territory Comprehensive Cancer Control Coalitions. Am J Health Educ (2013) 0.75

Scalable office-based health care. Health Serv Manage Res (2011) 0.75

How to improve colon cancer screening rates. World J Gastrointest Oncol (2015) 0.75

Effects of chemopreventive agents on the incidence of recurrent colorectal adenomas: a systematic review with network meta-analysis of randomized controlled trials. Onco Targets Ther (2017) 0.75

Articles by these authors

Patients' expectations about effects of chemotherapy for advanced cancer. N Engl J Med (2012) 10.93

Comparative effectiveness of minimally invasive vs open radical prostatectomy. JAMA (2009) 7.25

Trends in the treatment of ductal carcinoma in situ of the breast. J Natl Cancer Inst (2004) 7.01

Race and trust in the health care system. Public Health Rep (2003) 6.74

Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies. Lancet Oncol (2012) 5.70

The effect of Medicare Part D on drug and medical spending. N Engl J Med (2009) 5.55

Utility of the SEER-Medicare data to identify chemotherapy use. Med Care (2002) 5.07

Comparing costs and quality of care at retail clinics with that of other medical settings for 3 common illnesses. Ann Intern Med (2009) 4.61

Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nat Genet (2010) 4.51

A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. Nat Genet (2009) 4.38

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet (2013) 4.35

Utilization and outcomes of minimally invasive radical prostatectomy. J Clin Oncol (2008) 4.23

Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomized controlled trial. JAMA (2003) 4.22

Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Randomized Trial. Am J Obstet Gynecol (2002) 4.18

Associations between palliative chemotherapy and adult cancer patients' end of life care and place of death: prospective cohort study. BMJ (2014) 3.90

A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. Nat Genet (2010) 3.86

Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment. J Clin Oncol (2007) 3.84

Place of death: correlations with quality of life of patients with cancer and predictors of bereaved caregivers' mental health. J Clin Oncol (2010) 3.78

Cost sharing and adherence to tyrosine kinase inhibitors for patients with chronic myeloid leukemia. J Clin Oncol (2013) 3.70

Increased risk of rectal cancer after prostate radiation: a population-based study. Gastroenterology (2005) 3.58

Physician factors associated with discussions about end-of-life care. Cancer (2010) 3.54

Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ. J Clin Oncol (2009) 3.50

GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nat Genet (2013) 3.42

Association between lymph node evaluation for colon cancer and node positivity over the past 20 years. JAMA (2011) 3.41

Understanding disparities in donor behavior: race and gender differences in willingness to donate blood and cadaveric organs. Med Care (2002) 3.37

Systematic review: noninvasive testing for Chlamydia trachomatis and Neisseria gonorrhoeae. Ann Intern Med (2005) 3.31

Risk of pelvic fractures in older women following pelvic irradiation. JAMA (2005) 3.26

Duration of lactation and risk factors for maternal cardiovascular disease. Obstet Gynecol (2009) 3.18

Effectiveness of primary androgen-deprivation therapy for clinically localized prostate cancer. J Clin Oncol (2014) 3.17

Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology. Circulation (2010) 3.16

Risk of sequelae after Chlamydia trachomatis genital infection in women. J Infect Dis (2010) 3.15

Effect of increasing the intensity of implementing pneumonia guidelines: a randomized, controlled trial. Ann Intern Med (2005) 3.13

The impact of national health care reform on adults with severe mental disorders. Am J Psychiatry (2011) 3.06

Saving the National Children's Study. Epidemiology (2010) 3.02

Excess risk of chronic kidney disease among African-American versus white subjects in the United States: a population-based study of potential explanatory factors. J Am Soc Nephrol (2002) 2.96

Lymph node evaluation in colorectal cancer patients: a population-based study. J Natl Cancer Inst (2005) 2.91

Functional limitations in elderly female cancer survivors. J Natl Cancer Inst (2006) 2.89

Longitudinal effects of depression on glycemic control in veterans with Type 2 diabetes. Gen Hosp Psychiatry (2008) 2.89

The legacy of Tuskegee and trust in medical care: is Tuskegee responsible for race differences in mistrust of medical care? J Natl Med Assoc (2005) 2.68

Cesarean delivery rates vary tenfold among US hospitals; reducing variation may address quality and cost issues. Health Aff (Millwood) (2013) 2.66

The association of race/ethnicity, insurance status, and socioeconomic factors with breast cancer care. Cancer (2010) 2.63

Variation in patient-sharing networks of physicians across the United States. JAMA (2012) 2.59

Uric acid is as important as proteinuria in identifying fetal risk in women with gestational hypertension. Hypertension (2005) 2.58

Disability among elderly survivors of mechanical ventilation. Am J Respir Crit Care Med (2010) 2.50

Perceived discrimination and adherence to medical care in a racially integrated community. J Gen Intern Med (2007) 2.49

A population-based assessment of specialty physician involvement in cancer clinical trials. J Natl Cancer Inst (2011) 2.48

Patient reports of preventable problems and harms in primary health care. Ann Fam Med (2004) 2.46

Retail clinics, primary care physicians, and emergency departments: a comparison of patients' visits. Health Aff (Millwood) (2008) 2.44

Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium. J Natl Cancer Inst (2014) 2.40

Relationship between staff perceptions of hospital norms and hospital-level end-of-life treatment intensity. J Palliat Med (2007) 2.39

Is survival better at hospitals with higher "end-of-life" treatment intensity? Med Care (2010) 2.35

Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer. Ann Surg Oncol (2009) 2.33

Healthcare costs and long-term outcomes after acute respiratory distress syndrome: A phase III trial of inhaled nitric oxide. Crit Care Med (2006) 2.27

An explicit quality indicator set for measurement of quality of care in patients with cirrhosis. Clin Gastroenterol Hepatol (2010) 2.18

Immediate risk of suicide and cardiovascular death after a prostate cancer diagnosis: cohort study in the United States. J Natl Cancer Inst (2010) 2.18

Health reform and the scope of benefits for mental health and substance use disorder services. Psychiatr Serv (2010) 2.18

The liver in heart failure. Clin Liver Dis (2002) 2.17

Trends in mammography screening rates after publication of the 2009 US Preventive Services Task Force recommendations. Cancer (2013) 2.14

Evidence-based risk communication: a systematic review. Ann Intern Med (2014) 2.14

Risk of early or severe pre-eclampsia related to pre-existing conditions. Int J Epidemiol (2007) 2.14

A randomized trial of behavioral management for continence with older rural women. Res Nurs Health (2002) 2.13

The risk of preeclampsia rises with increasing prepregnancy body mass index. Ann Epidemiol (2005) 2.12

Deceased donor kidney and liver transplantation to nonresident aliens in the United States. Transplantation (2007) 2.11

Willingness to pay for a quality-adjusted life year: implications for societal health care resource allocation. Med Decis Making (2005) 2.10

The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing. Clin Cancer Res (2011) 2.09

End-of-life care discussions among patients with advanced cancer: a cohort study. Ann Intern Med (2012) 2.08

Association between length of residence and cardiovascular disease risk factors among an ethnically diverse group of United States immigrants. J Gen Intern Med (2007) 2.07

Determinants of willingness to donate living related and cadaveric organs: identifying opportunities for intervention. Transplantation (2002) 2.06

Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology. CA Cancer J Clin (2010) 2.05

Bone lead levels in adjudicated delinquents. A case control study. Neurotoxicol Teratol (2002) 2.04

The effects of the coverage gap on drug spending: a closer look at Medicare Part D. Health Aff (Millwood) (2009) 2.02

Survival of older patients with cancer in the Veterans Health Administration versus fee-for-service Medicare. J Clin Oncol (2012) 2.00

Associations between end-of-life discussion characteristics and care received near death: a prospective cohort study. J Clin Oncol (2012) 1.95

Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer. Cancer Res (2007) 1.92

Medicaid, Medicare, and the Michigan Tumor Registry: a linkage strategy. Med Decis Making (2007) 1.92

Reduction in physician reimbursement and use of hormone therapy in prostate cancer. J Natl Cancer Inst (2010) 1.91

Incidence of second malignancies among patients treated with proton versus photon radiation. Int J Radiat Oncol Biol Phys (2013) 1.89

The development and deployment of Common Data Elements for tissue banks for translational research in cancer - an emerging standard based approach for the Mesothelioma Virtual Tissue Bank. BMC Cancer (2008) 1.88

The role of primary care physicians in cancer care. J Gen Intern Med (2009) 1.87

Network meta-analysis of margin threshold for women with ductal carcinoma in situ. J Natl Cancer Inst (2012) 1.87

A snapshot of smokers after lung and colorectal cancer diagnosis. Cancer (2012) 1.85

Biospecimen reporting for improved study quality (BRISQ). Cancer Cytopathol (2011) 1.85

Depression, stress, and social support as predictors of high-risk sexual behaviors and STIs in young women. J Adolesc Health (2006) 1.84

National health care costs of peripheral arterial disease in the Medicare population. Vasc Med (2008) 1.83

The influence of race and religion on abstinence from alcohol, cigarettes and marijuana among adolescents. J Stud Alcohol (2003) 1.82

Explaining racial differences in prostate cancer mortality. Cancer (2012) 1.82

Using simulation to isolate physician variation in intensive care unit admission decision making for critically ill elders with end-stage cancer: a pilot feasibility study. Crit Care Med (2008) 1.81

Discussions with physicians about hospice among patients with metastatic lung cancer. Arch Intern Med (2009) 1.77

Persistence of racial disparities in advance care plan documents among nursing home residents. J Am Geriatr Soc (2002) 1.76

Are mastectomy rates really increasing in the United States? J Clin Oncol (2010) 1.75

Medicare Part D and nursing home residents. J Am Geriatr Soc (2007) 1.74

Differences in clinical trial patient attributes and outcomes according to enrollment setting. J Clin Oncol (2009) 1.74

Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nat Commun (2013) 1.73

Procedural experience with out-of-hospital endotracheal intubation. Crit Care Med (2005) 1.72

Gastrointestinal bleeding in the elderly. Nat Clin Pract Gastroenterol Hepatol (2008) 1.71

Cost-effective diagnostic checklists for meningitis in resource-limited settings. J Acquir Immune Defic Syndr (2013) 1.71

Is spending more always wasteful? The appropriateness of care and outcomes among colorectal cancer patients. Health Aff (Millwood) (2008) 1.70

Periconceptional multivitamin use reduces the risk of preeclampsia. Am J Epidemiol (2006) 1.70

Home screening for sexually transmitted diseases in high-risk young women: randomised controlled trial. Sex Transm Infect (2007) 1.70